The intravenous and oral pharmacokinetics of lotilaner in dogs

[1]  Jason Drake,et al.  Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs , 2017, Parasites & Vectors.

[2]  S. Wiseman,et al.  A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA , 2017, Parasites & Vectors.

[3]  E. A. Kuntz,et al.  Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™) , 2017, Parasites & Vectors.

[4]  Jason Drake,et al.  Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs , 2017, Parasites & Vectors.

[5]  Jason Drake,et al.  Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs , 2017, Parasites & Vectors.

[6]  Jason Drake,et al.  A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries , 2017, Parasites & Vectors.

[7]  Jason Drake,et al.  Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs , 2017, Parasites & Vectors.

[8]  S. Menon,et al.  Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs. , 2016, Veterinary parasitology.

[9]  L. Letendre,et al.  The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. , 2014, Veterinary parasitology.

[10]  P. Confalone,et al.  Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. , 2014, Veterinary parasitology.

[11]  T. Ilg,et al.  The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity. , 2014, Insect biochemistry and molecular biology.

[12]  Rainer K. A. Roepke,et al.  Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration , 2014, Parasites & Vectors.

[13]  Rainer K. A. Roepke,et al.  The effect of food on the pharmacokinetics of oral fluralaner in dogs , 2014, Parasites & Vectors.

[14]  M. Dryden,et al.  Insecticide/acaricide resistance in fleas and ticks infesting dogs and cats , 2014, Parasites & Vectors.

[15]  C. Holyoke,et al.  4-Azolylphenyl isoxazoline insecticides acting at the GABA gated chloride channel. , 2013, Bioorganic & medicinal chemistry letters.

[16]  M. Asahi,et al.  The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. , 2010, Biochemical and biophysical research communications.

[17]  P. Toutain,et al.  Plasma terminal half-life. , 2004, Journal of veterinary pharmacology and therapeutics.

[18]  P. Toutain,et al.  Bioavailability and its assessment. , 2004, Journal of veterinary pharmacology and therapeutics.

[19]  P. Toutain,et al.  Volumes of distribution. , 2004, Journal of veterinary pharmacology and therapeutics.

[20]  F. Jongejan,et al.  The global importance of ticks , 2004, Parasitology.

[21]  M. Rust,et al.  The biology, ecology, and management of the cat flea. , 1997, Annual review of entomology.

[22]  Dwight D. Bowman,et al.  Georgis' Parasitology for Veterinarians , 1995 .